Evidence map›Paper›PMID 11598088›Full record

ArticleInfection and immunity2001

Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells.

S F Fischer, C Schwarz, J Vier, G Häcker

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 115 citations in OpenAlex.

  1. Review
  2. Microorganisms · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Prediction ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2017
    Article
  9. Article
  10. An epistatic effect of apaf-1 and caspase-9 on chlamydial infection.Apoptosis : an international journal on programmed cell death · 2015
    Article
  11. Article
  12. Chlamydial intracellular survival strategies.Cold Spring Harbor perspectives in medicine · 2013
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S F FischerInstitute for Medical Microbiology, Technische Universität München, D-81675 Munich, Germany.
C Schwarz
J Vier
G Häcker
Technical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydia pneumoniae is an obligate intracellular bacterium which frequently causes airway infection in humans and has been implicated in atherosclerosis. Here we show that infection with C. pneumoniae protects HeLa human epithelioid cells against apoptosis induced by external stimuli. In infected HeLa cells, apoptosis induced by staurosporine and CD95-death-receptor signaling was strongly reduced. Upon treatment with staurosporine, generation of effector caspase activity, processing of caspase-3 and caspase-9 and cytochrome c redistribution were all profoundly inhibited in cells infected with C. pneumoniae. Bacterial protein synthesis during early infection was required for this inhibition. Furthermore, cytochrome c-induced processing and activation of caspases were inhibited in cytosolic extracts from infected cells, suggesting that a C. pneumoniae-dependent antiapoptotic factor was generated in the cytosol upon infection. Infection with C. pneumoniae failed to induce significant NF-kappaB activation in HeLa cells, indicating that no NF-kappaB-dependent cellular factors were involved in the protection against apoptosis. These results show that C. pneumoniae is capable of interfering with the host cell's apoptotic apparatus at probably at least two steps in signal transduction and might explain the propensity of these bacteria to cause chronic infections in humans.

Indexed as

Apoptosis2,4-DinitrophenolBacterial ProteinsCaspase 3Caspase 9CaspasesChlamydophila pneumoniaeCytochrome c GroupEnzyme Activationfas ReceptorHeLa CellsHumansMitochondriaNF-kappa BTranscription, GeneticTumor Cells, Cultured2,4-DinitrophenolBacterial ProteinsCASP3 protein, humanCASP9 protein, humanCaspase 3Caspase 9CaspasesCytochrome c Groupfas ReceptorNF-kappa B

Identifiers

PMID11598088
PMCPMC100101
OpenAlexW2093633496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.